EverHint Signal — EMA10 × EMA30 Crossover — December 11, 2025

What This Signal Is (Quick)

The EMA10 × EMA30 Crossover scanner detects fresh momentum shifts by tracking when the 10-day exponential moving average crosses the 30-day EMA:

• Buy signals: EMA10 crosses above EMA30 — short-term momentum accelerates past the medium-term trend, suggesting upward price movement may continue
• Sell signals: EMA10 crosses below EMA30 — short-term momentum weakens below the medium-term trend, potentially signaling deceleration or reversal

This dual-EMA system responds faster to price changes than our EMA10 × SMA50 strategy, generating more frequent signals but also carrying higher whipsaw risk in choppy markets. It's ideal for swing traders targeting 1-4 week holding periods in trending environments.

This is an experimental scanner focused on momentum capture. Signals are for educational use and back-testing—not financial advice. Always conduct your own due diligence.

How We Ranked Today (Reader Version)

Buy signals are ranked by RSI (14-day) in ascending order—lower RSI values suggest more oversold conditions, which can present better risk/reward entry points when combined with bullish crossovers. Stocks trading at RSI below 40 are particularly stretched and may offer stronger mean-reversion potential alongside the momentum signal.

Sell signals are also ranked by RSI ascending—lower RSI on a sell signal can indicate a stock that's already weakened significantly, while higher RSI suggests a pullback from overbought levels.

We overlay three critical data points:

1. Insider flows (last 90 days): Net insider buying during crossovers adds conviction—executives putting their capital to work alongside technical signals
2. Earnings proximity: Companies reporting within 7-30 days face event risk that can accelerate or invalidate crossover signals
3. 200-day SMA context: Crossovers above the 200-day SMA occur in established uptrends; those below suggest counter-trend rallies

Market context: Broader indices finished positive (S&P 500 +0.58%, Dow +1.31%, Nasdaq +0.36%), VIX dropped 11.8% to 14.85, and small-caps rallied +1.16%. This risk-on environment supports breakout signals, though traders should remain alert to quick reversals given recent volatility compression.

📈 Buy-Side Signals (EMA10 Crosses Above EMA30)

Top 59 Buy Signals — December 11, 2025

📉 Sell-Side Signals (EMA10 Crosses Below EMA30)

12 Sell Signals — December 11, 2025

Field Notes

RSI(14): Momentum indicator on 0-100 scale. Buy signals with RSI below 40 (INCY at 34.9, NKTR at 38.7, XPEV at 40.7) suggest oversold conditions—crossovers from extreme lows can produce strong bounces. Conversely, buy signals with RSI above 80 (ACMR at 92.2, ZBRA at 92.1, TBBK at 87.5) indicate overbought momentum—breakouts from strength that require careful position sizing.

Insider Net: Net insider buying (+) or selling (-) over the past 90 days. BAH stands out with +$2.0M—CEO Horacio Rozanski purchased 23,800 shares at $84.66 on October 30, demonstrating conviction during a pullback. LUNR shows +$2.2M from director Michael Blitzer buying 241,080 shares at $8.83-$9.27 in mid-November. OMC director Philip Krakowsky received $5.8M in awards tied to performance milestones. On the sell side, MRCY saw -$75.5M from activist investor Jana Partners reducing their stake, ADPT insiders sold -$6.5M, and INTU executives systematically sold -$4.7M.

Sector Rotation: Financial Services led with 13 buy signals (ALL, AEG, AIG, CRBG, EQH, GL, GPN, SEIC, SIGI, SPGI, TBBK, VOYA, plus one sell in AEG), followed by Industrials with 15 buy signals. Healthcare showed mixed signals—8 buy signals but 6 sell signals, suggesting sector-wide uncertainty. Technology had 10 buy signals led by high-RSI names like ACMR and ZBRA.

Earnings Proximity: Most signals report earnings in 48-90 days (late January to mid-February 2026). AIR reports in just 25 days (January 6), creating near-term event risk. Companies with no reported earnings dates (LUNR, AEG, CCEP, XPEV, CNR) require extra caution—lack of analyst coverage can mean lower liquidity or higher uncertainty.

200-day SMA Context: Most buy signals trade above their 200-day moving averages, indicating crossovers within established uptrends. Notable exceptions include CVS ($80.84 vs $69.90 SMA200) and INTU ($675.88 vs $677.50 SMA200)—these are consolidating near long-term support/resistance.

Recent Headlines

Buy-Side Highlights:

• BAH (Booz Allen Hamilton): CEO Horacio Rozanski's $2M insider buy at $84.66 underscores confidence amid the company's strategic push into cybersecurity, AI, and defense tech. Zacks highlighted BAH's expanding MRO capacity and strong liquidity as growth catalysts.

• LUNR (Intuitive Machines): Director Michael Blitzer accumulated $2.2M in shares during November weakness. The company recently acquired Lanteris Space Systems, evolving into a full-service space contractor across all orbital regimes. Stock down 36% YTD despite recent 22% surge.

• INTU (Intuit): Systematic insider selling by director Scott Cook ($4.5M sold in recent weeks) appears to be routine profit-taking. Stock trades near 200-day SMA at $677, consolidating after strong run.

• NOK (Nokia): Nvidia's $1B investment sent shares to multiyear highs in October. Stock has pulled back but analysts see potential for $10+ in 2026 driven by 5G network API partnerships with Airtel and continued AI infrastructure build-out.

• RKLB (Rocket Lab): Executives sold modest amounts in September-November ($554K net). Company extends distribution agreements and maintains strong launch cadence. Reports earnings February 26.

• ALL (Allstate): Modest insider selling (-$1.3M) offset by strong industry fundamentals. Goldman Sachs conference highlighted pricing power and prudent underwriting lifting P&C insurance sector. Zacks named ALL a top-ranked stock for 2026.

• RTX (RTX Corporation): Minor insider activity (-$1.5M). Defense contractor reports earnings January 27. Stock trading above 200-day SMA with momentum building.

• AIG, CRBG, EQH, GL, SPGI: Financial services names showing broad-based momentum as rates stabilize. EQH CEO Mark Pearson sold $106K in routine transactions. Most signals trade above long-term averages.

• ENPH (Enphase Energy): CEO Badrinarayanan Kothandaraman bought $309K worth of shares at $30.93 on October 31—bullish signal in beaten-down solar sector. Stock bounced sharply from lows.

Sell-Side Highlights:

• NKTR (Nektar Therapeutics): Despite sell signal, insiders bought +$3.6M in stock awards valued at $281.25/share in late November. Current price at $51.11 suggests significant discount to insider award value—warrants monitoring for reversal.

• ADPT (Adaptive Biotechnologies): CEO Chad Robins systematically sold -$6.5M in recent months. Company showcased MRD leadership at ASH Annual Meeting with 90 abstracts featuring clonoSEQ data. Sell crossover may be profit-taking after biotech run.

• A (Agilent Technologies): Wall Street analysts issued mixed calls. Stock trading above 200-day SMA at $124, so sell crossover could signal consolidation rather than breakdown.

• INCY, BMRN, QGEN: Healthcare names showing weakness. No significant insider activity. Sector rotation away from biotech/pharma into cyclicals.

• TTWO (Take-Two Interactive): Gaming stock crossing below EMA30 despite trading above 200-day SMA. No insider activity. Reports earnings February 5.

• CWEN (Clearway Energy): Utilities name with extremely low RSI (19.9) on sell crossover—deeply oversold but momentum remains negative. No earnings date listed.

Vlad's Take (EverHint)

December 11 delivered a clean risk-on session: S&P 500 +0.58%, Dow +1.31%, Nasdaq +0.36%, Russell 2000 +1.16%. VIX collapsed 11.8% to 14.85—complacency is creeping back in. Bitcoin rallied +1.12% to $93,067, gold jumped +1.19% to $4,309, and the dollar index dropped -0.23%. Treasury yields rose modestly (10Y at 4.14%), but not enough to derail growth stocks. This is the ideal environment for EMA crossover signals: trending markets with low volatility and broadening participation.

What stands out:

1. Insider buying in buy-side crossovers is rare and bullish: BAH CEO buying $2M at $84.66, LUNR director buying $2.2M at $8.83-$9.27, ENPH CEO buying $309K at $30.93—these aren't token purchases. Executives are stepping in during technical breakouts, adding fundamental conviction to momentum signals. Pay close attention to these names.

2. Financial Services leading the charge: Thirteen buy signals across insurers (ALL, AIG, GL, SIGI), asset managers (SPGI, SEIC), and diversified financials (EQH, CRBG, VOYA) suggest the sector is breaking out as rates stabilize and growth expectations firm. This is rotational strength, not just index-driven beta.

3. Healthcare is schizophrenic: Eight buy signals (MOH, OPCH, CVS, TFX, ASND) but six sell signals (A, INCY, BMRN, QGEN, ELAN, ADPT). The sector lacks conviction. Avoid chasing healthcare crossovers until directional clarity emerges.

4. High-RSI breakouts require discipline: ACMR (92.2), ZBRA (92.1), TBBK (87.5), MOH (83.7), BAH (82.6)—these are already extended. Crossovers from overbought levels can continue higher in strong trends, but position sizing must be smaller and stops tighter. Don't chase—wait for pullbacks to the EMA30 or enter in thirds.

5. Sell signals don't mean "short immediately": NKTR insiders awarded themselves shares at $281.25 but the stock trades at $51—that's an 82% discount. The sell crossover may be temporary weakness before a reversal. Similarly, A and TTWO trade above their 200-day SMAs—these are consolidations, not collapses. Use sell signals as alerts to tighten stops on existing longs, not automatic short triggers.

Trading tips for EMA crossovers:

• Entry timing: Don't chase the close of the crossover day. Wait for a retest of the EMA10 (ideally touching or slightly undercutting it) before entering. This improves risk/reward and reduces whipsaw risk.
• Position sizing: Start with 50% of intended position size on initial entry. Add the other 50% if price holds above EMA10 for 2-3 days. Cut the entire position if price closes below EMA30.
• Stop loss: Place stops below the EMA30 for buy signals (tighter for high-RSI names). For sell signals, stops go above EMA30. EMAs are dynamic—adjust stops weekly.
• Take profit: Target 5-10% gains or previous swing highs. EMAs are momentum signals, not long-term holds. Lock in profits aggressively—crossovers can reverse quickly.
• Earnings risk: Avoid positions within 7 days of earnings (like AIR at 25 days out). Consider reducing size or exiting entirely 2-3 days before reports.

Risk warning: EMA crossovers excel in trending markets but suffer in range-bound chop. Today's low VIX (14.85) suggests compressed volatility—watch for sudden VIX spikes above 20, which historically kill momentum strategies. If indices roll over or VIX explodes, exit crossover trades immediately. These are not buy-and-hold positions.

🔔 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/